Refine
Year of publication
Document Type
- Contribution to a Periodical (455)
- Article (37)
- Review (10)
- Preprint (5)
- Conference Proceeding (1)
Has Fulltext
- yes (508) (remove)
Is part of the Bibliography
- no (508)
Keywords
- Angiogenesis (2)
- Wound healing (2)
- aging (2)
- 3years (1)
- ALK-rearranged NSCLC (1)
- Acute kidney injury (1)
- Antirheumatic agents (1)
- Blood loss (1)
- COVID-19 (1)
- CVD biomarker (1)
Institute
- Präsidium (477)
- Gesellschaftswissenschaften (42)
- Neuere Philologien (39)
- Medizin (29)
- Biowissenschaften (12)
- Erziehungswissenschaften (11)
- Physik (10)
- Universitätsbibliothek (10)
- Rechtswissenschaft (9)
- Wirtschaftswissenschaften (8)
Introduction: The Retro-IDEAL (ILUVIEN Implant for chronic DiabEtic MAcuLar edema) study is a retrospective study designed to assess real-world outcomes achieved with the ILUVIEN® (0.19 mg fluocinolone acetonide (FAc)) in patients with chronic diabetic macular edema (DME) in clinical practices in Germany.
Methods: This study was conducted across 16 sites in Germany and involved 81 eyes (63 patients) with persistent or recurrent DME and a prior suboptimal response to a first-line intravitreal therapy (primarily anti-VEGF intravitreal therapies).
Results: Patients were followed-up for 30.8 ± 11.3 months (mean ± standard deviation) and had a mean age of 68.0 ± 10.4 years. Best-recorded visual acuity (BRVA) improved by +5.5 letters at month 9 (P ⩽ 0.005, n=56; from a baseline of 49 letters) and this was maintained through to month 30 (P ⩽ 0.05, n = 42). There was a concurrent improvement in central macular thickness with a reduction from 502 µm at baseline to 338 µm at year 1 (P ⩽ 0.0001, n = 43). This effect was sustained to year 3 (i.e. 318 µm; P ⩽ 0.0001, n = 29). Mean intraocular pressure (IOP) remained constant between baseline and year 3 with a peak change of 1.9 mm Hg occurring at year 1. Elevated IOP was observed in a similar percentage of patients prior to (22.2% of cases) and following (27.2%) treatment with the FAc implant. In the majority of cases, these elevations were managed effectively with IOP medications.
Conclusions: Despite substantial amounts of prior intravitreal treatments – primarily with anti–vascular endothelial growth factor (VEGF) drugs – this real-world study showed that sustained structural and functional improvements can last for up to 3 years with a single FAc implant.
Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima-media thickness, (cIMT) are predictive of cardiovascular disease (CVD) events in individuals. Whether this is true for conventional risk factors is unclear.
Methods and results: An individual participant meta-analysis was used to associate the annualised progression of systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with future cardiovascular disease risk in 13 prospective cohort studies of the PROG-IMT collaboration (n = 34,072). Follow-up data included information on a combined cardiovascular disease endpoint of myocardial infarction, stroke, or vascular death. In secondary analyses, annualised progression was replaced with average. Log hazard ratios per standard deviation difference were pooled across studies by a random effects meta-analysis. In primary analysis, the annualised progression of total cholesterol was marginally related to a higher cardiovascular disease risk (hazard ratio (HR) 1.04, 95% confidence interval (CI) 1.00 to 1.07). The annualised progression of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol was not associated with future cardiovascular disease risk. In secondary analysis, average systolic blood pressure (HR 1.20 95% CI 1.11 to 1.29) and low-density lipoprotein cholesterol (HR 1.09, 95% CI 1.02 to 1.16) were related to a greater, while high-density lipoprotein cholesterol (HR 0.92, 95% CI 0.88 to 0.97) was related to a lower risk of future cardiovascular disease events.
Conclusion: Averaged measurements of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol displayed significant linear relationships with the risk of future cardiovascular disease events. However, there was no clear association between the annualised progression of these conventional risk factors in individuals with the risk of future clinical endpoints.
Vom 19. bis 21. September fand im Forschungskolleg Humanwissenschaften die bereits dritte Bad Homburg Conference statt. Die Konferenz zum Thema Künstliche Intelligenz brachte Perspektiven aus verschiedenen wissenschaftlichen Disziplinen und der Praxis zusammen. Referentinnen und Referenten u. a. aus Informatik, Rechtswissenschaft, Medizin, Philosophie und Hirnforschung diskutierten mit Vertretern der gesellschaftlichen Praxis: Unternehmern, Industrievertretern, einem Kriminalhauptkommissar des Landeskriminalamts Hessen und einer Bürgerrechtsaktivistin und Politikberaterin aus den USA. Begrüßt wurden die Teilnehmer von ForschungskollegDirektor Prof. Dr. Matthias Lutz-Bachmann, der Vizepräsidentin der Goethe-Universität, Prof. Dr. Simone Fulda, dem Bürgermeister der Stadt Bad Homburg, Meinhard Matern, sowie der Hessischen Ministerin für Digitale Strategie und Entwicklung, Prof. Dr. Kristina Sinemus. Der Abschlusskommentar kam von Christoph Burchard, Professor für Straf- und Strafprozessrecht, Internationales und Europäisches Strafrecht, Rechtsvergleichung und Rechtstheorie an der Goethe-Universität. Der UniReport hatte Gelegenheit, mit Christoph Burchard nach der Konferenz zu sprechen.
Die diesjährige Inhaberin der Alfred-Grosser-Gastprofessur des Fachbereichs Gesellschaftswissenschaften, eine Kooperation mit der Stiftung Polytechnische Gesellschaft Frankfurt am Main, ist Prof. Dr. Astrid von Busekist, seit 2001 Professorin für Politische Theorie an der Sciences Po in Paris. Ihr stadtöffentlicher Vortrag mit dem Titel »Träume von Räumen. Exkurs über die Grenze« findet digital am Dienstag, 23. Februar 2021, um 19.00 Uhr c.t. statt.
Prof. Karin Böhning-Gaese, seit 2010 Direktorin des Senckenberg Biodiversität und Klima Forschungszentrums in Frankfurt am Main und Professorin an der Goethe-Universität, wurde in den Rat für Nachhaltige Entwicklung berufen. Das 15-köpfige Gremium berät die Bundesregierung, erarbeitet Beiträge zur Fortentwicklung der Nachhaltigkeitsstrategie, veröffentlicht Stellungnahmen zu Einzelthemen und soll zur öffentlichen Bewusstseinsbildung und zur gesellschaftlichen Debatte über Nachhaltigkeit beitragen.